HNI vs La-Z-Boy
HNI and LZB side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HNI and LZB compare
HNI is the larger company, worth 2.8 times as much as La-Z-Boy ($3.4B against $1.2B).
On earnings, La-Z-Boy is cheaper: it trades at 17.5× trailing earnings, against 425× for HNI.
HNI grew revenue faster over the last twelve months (70.1% versus 0.30% for La-Z-Boy).
La-Z-Boy keeps more of each dollar of sales as profit, with a net margin of 3.3% compared with 0.10% at HNI.
Both pay dividends: HNI yields 2.2% and La-Z-Boy 3.2%.
La-Z-Boy scores higher on the StockData Score (13 against 7 for HNI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HNI | LZB |
|---|---|---|
| Size and price | ||
| Market cap | $3.4B | $1.2B |
| Share price | $46.75 | $30.33 |
| Change, 1 year | 19.3% | −0.10% |
| Change, 5 years | 14.7% | −12.9% |
| Beta (5Y) | 0.91 | 1.02 |
| Employees | 20K | 10K |
| StockData Score | ||
| Total score | 7 | 13 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 1 | 5 (better) |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 425× | 17.5× (better) |
| P/S | 0.8× | 0.6× (better) |
| P/B | 1.9× | 1.2× (better) |
| EV/EBITDA | 16.2× | 7.0× (better) |
| P/FCF | – | 14.5× |
| FCF yield | – | 6.9% |
| Fair value | $24.52 | $29.97 |
| Margin of safety | −90.7% | −1.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 70.1% (better) | 0.30% |
| Revenue growth, 5Y average | 7.7% (better) | 4.2% |
| Net income growth (TTM) | −97.1% | −22.1% (better) |
| EPS growth (TTM) | −96.4% | −20.3% (better) |
| EPS growth, 5Y average | 2.5% (better) | 1.4% |
| Profitability | ||
| Gross margin | 41.0% | 44.5% (better) |
| Operating margin | 2.0% | 4.3% (better) |
| Net margin | 0.10% | 3.3% (better) |
| FCF margin | – | 4.0% |
| Return on equity | 0.33% | 6.9% (better) |
| Return on invested capital | 2.1% | 9.4% (better) |
| Financial health | ||
| Debt / equity | 0.76 (better) | 0.00 |
| Net debt / EBITDA | 4.41 | – |
| Interest coverage | – | 148× |
| Current ratio | 1.36 | 1.62 (better) |
| Altman Z-score | 1.74 | 2.54 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | 3.2% (better) |
| Payout ratio | 1937% | 55.6% |
| Years of dividend growth | 15 (better) | 0 |
| Dividend growth, 5Y average | 2.0% | 16.2% (better) |
| Buyback yield | 0.01% | 6.7% (better) |
| Shareholder yield | 2.2% | 9.9% (better) |
| Ownership | ||
| Held by institutions | 87.8% | 102% |
| Held by insiders | 1.9% | 2.3% |
| Insider net buying, 12 months | −$4.8M | −$3.0M (better) |
| Short interest, % of float | 5.4% | 5.2% |
Go deeper
- HNI stock overview
- HNI income statement
- HNI valuation and score
- LZB stock overview
- LZB income statement
- LZB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.